do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Frontiers The effect of DPP-4 inhibitors,
Description
This approach can also result in increased production of other hormones produced by L-cells such as oxyntomodulin and peptide YY (PYY), which can enhance the metabolic effects of GLP-1
Accordingly, better control of cardiovascular risk factors such as blood pressure (BP) in patients with T2D is required to achieve favorable cardiovascular safety goals
obesity vs
Figure 3
Cholesterol is essential for hormone synthesis and cell membranes
